Simulation modeling of multi-layer protective screen

2021 ◽  
Author(s):  
V. V. Zelentsov ◽  
Zhou Xiao
Keyword(s):  
Simulation Modeling ◽  
Protective Screen

2020–2021 Florida Citrus Production Guide: Citrus Under Protective Screen (CUPS) Production Systems

EDIS ◽  
2020 ◽  
Author(s):  
Arnold W. Schumann ◽  
Ariel Singerman ◽  
Alan L. Wright ◽  
Rhuanito S. Ferrarezi
Keyword(s):  
Production Systems ◽  
Citrus Production ◽  
Florida Citrus ◽  
Protective Screen

Method for Assessing the Ecological Risk to the Population in Areas Outside the Planning Zones of Emergency Protection Measures Around the NPP

2020 ◽  
Vol 17 (5) ◽  
pp. 34-47
Author(s):  
V. M. Polyakov ◽  
Z. S. Agalarov
Keyword(s):  
Ecological Risk ◽  
Environmental Risk ◽  
Risk Taking ◽  
Late Stage ◽  
Simulation Modeling ◽  
Radiation Accident ◽  
Emergency Protection ◽  
Protection Measures ◽  
Vector Criterion

The article offers a method for assessing the environmental risk in the territories adjacent to the planning zone of emergency protection measures around the NPP. The method is based on simulation modeling of territory pollution, which is formed at the late stage of a radiation accident and zoning of territories by risk, taking into account the characteristics of the population’s life in a potentially dangerous territory. A vector criterion of environmental risk is proposed that allows zoning these territories according to the degree of danger to the population.

Offer of methods for minimizing key investment risks of “R-Pharm” JSC

2020 ◽  
Vol 17 (1) ◽  
pp. 58-67
Author(s):  
N. A. Kabanova ◽  
I. K. Alekseeva
Keyword(s):  
Strategic Planning ◽  
Pharmaceutical Company ◽  
Simulation Modeling ◽  
Return On Investment ◽  
System Analysis ◽  
Social Orientation ◽  
Pharmaceutical Companies ◽  
The Subject ◽  
High Degree

The article is devoted to the assessment of potential investment risks of the pharmaceutical company “R-Pharm” JSC with the aim of identifying the highest priority risks and developing methods for minimizing them. The relevance of the study is determined by the fact that the pharmaceutical business is characterized by a high degree of social orientation and annually invests $ 140 billion in the development of production and research, which determines the need for a risk-based approach to ensure the return on investment. The subject of this article is the investment risks of pharmaceutical companies, and the subject of research is the domestic pharmaceutical company “R-Pharm”. In order to assess the potential investment risks of “R-Pharm” JSC, the authors used elements of simulation modeling and system analysis. The proposed methods to minimize key investment risks are aimed at improving the efficiency of investment activities and is recommended as an element of the strategic planning of the company.

Sign in / Sign up

Export Citation Format

Share Document